HCPCS Level II · Procedures and professional services (temporary)
G0684Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About G0684
G0684 is an HCPCS Level II code in the G series (procedures and professional services (temporary)), describing application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure).
It was added to HCPCS effective 01/01/2026.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- App non-sheet skin sb g addl
- Date added
- 01/01/2026
- Action effective
- 01/01/2026
- BETOS
- P5A
Related G06xx codes
- G0659Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes
- G0660Team remote e/m new pt 10mins
- G0661Team remote e/m new pt 20mins
- G0662Team remote e/m new pt 30 mins
- G0663Team remote e/m new pt 45mins
- G0664Team remote e/m new pt 60mins
- G0665Team remote e/m est. pt 10mins
- G0666Team remote e/m est. pt 15mins
- G0667Team remote e/m est. pt 25mins
- G0668Team remote e/m est. pt 40mins
- G0669Outcome-aligned payment (oap) for technology-enabled chronic care management of early cardio-kidney-metabolic (eckm) conditions (hypertension, or two or more of: dyslipidemia, obesity/overweight with central obesity marker, prediabetes); initial 12-month period; per month
- G0670Outcome-aligned payment (oap) for technology-enabled chronic care management of early cardio-kidney-metabolic (eckm) conditions (hypertension, or two or more of: dyslipidemia, obesity/overweight with central obesity marker, prediabetes); follow-on 12-month period; per month
Common questions about G0684
Is HCPCS G0684 still valid?
- Yes. G0684 is active in the CMS October 2026 HCPCS file.
Does Medicare cover G0684?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.